10-Q: ReposiTrak Q3 2026 Earnings: Revenue Dip, Profit Growth
Quarterly Report
ReposiTrak, Inc. reported a slight revenue decrease in Q3 2026 compared to the prior year, but saw an increase in net income driven by operational efficiencies and strategic focus on recurring revenue.
Summary
- ReposiTrak, Inc. reported revenue of $5.88 million for the third quarter ended March 31, 2026, a 1% decrease from $5.91 million in the same period last year.
- Net income for the quarter was $1.99 million, an increase from $1.97 million in the prior year's quarter.
- For the nine months ended March 31, 2026, revenue increased by 5% to $17.71 million from $16.85 million in the prior year.
- Net income for the nine-month period rose to $5.49 million from $5.18 million in the prior year.
- The company's cash and cash equivalents decreased by 8% to $26.41 million from $28.57 million.
- Operating expenses decreased by 12% in cost of services and product support and 4% in sales and marketing for the quarter.
- The company declared a quarterly cash dividend of $0.02 per share, payable in May 2026.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this filing as moderately positive, with solid net income growth and strategic progress in key areas like traceability, despite a slight dip in quarterly revenue.
Positives
- Net income increased for both the three-month ($1.99M vs $1.97M) and nine-month ($5.49M vs $5.18M) periods.
- Revenue for the nine-month period increased by 5% to $17.71 million.
- Operating expenses decreased in key areas: cost of services and product support (12% for Q3) and sales and marketing (4% for Q3).
- The company continues to focus on recurring subscription revenue, deemphasizing transactional revenue.
- The company has a strong current ratio of 4.89 as of March 31, 2026.
- The company has no bank debt as of March 31, 2026.
- The company declared a quarterly cash dividend of $0.02 per share.
Negatives
- Revenue for the three-month period decreased by 1% to $5.88 million.
- Cash and cash equivalents decreased by 8% to $26.41 million.
- Net cash provided by operating activities decreased by 13% for the nine-month period.
- Net cash used in investing activities increased significantly due to a $3 million note receivable issuance.
- Net cash used in financing activities increased by 31% due to increased common stock buybacks.
Risks
- The company is exposed to credit risk associated with the financial condition of SPAR Marketing Force, Inc., the borrower of a $3 million note receivable.
- The note receivable with SPAR Marketing Force, Inc. includes price protection provisions that could require cash payments to the company if SPAR Group, Inc. stock price falls below certain levels.
- The company's future interest income may fall short of expectations due to changes in interest rates, or it may suffer principal losses if forced to sell securities that have fallen in value.
- The company's ability to collect principal, interest, and any contingent consideration from SPAR Marketing Force, Inc. is dependent on the financial condition and operating performance of the Borrower.
Future Outlook
The company believes its existing cash and short-term investments, along with funds generated from operations, are sufficient to meet operating and investment needs for at least the next twelve months. Future capital requirements will depend on macroeconomic conditions, revenue growth rate, sales and marketing activities, R&D spending, and market acceptance of its products and services. Management anticipates continued increase in cash flow from operations and working capital, which will be used to fund quarterly cash dividends and preferred stock redemptions.
Management Comments
- The decrease in revenue for the three months ended March 31, 2026, was due to the timing of a large increase in onboarding fees that occurred in fiscal 2025 that did not occur in the same period of fiscal 2026, offset partially by growth in all lines of business.
- We continue to focus our sales efforts on marketing our software services on a recurring subscription basis and placing less emphasis on transactional revenue.
- The demand in traceability has required additional development of software used on the ReposiTrak platform in order to accurately meet the complex requirements of FSMA 204 in addition to further accelerate the systematic onboarding of customers with little if any human intervention.
- We believe marketing spending, excluding commissions and other variable costs due to sales volumes, will flatten over time as awareness of the traceability regulatory deadline approaches and the industry continues to mandate early adoption.
- The increase in sales and marketing expense resulted from increased commissions paid due to higher sales and FSMA 204 traceability awareness marketing.
- The Company announced that it intends to redeem all of the Series B and B-1 Preferred on or before December 2026.
- Management currently believes that the Company will continue to increase its cash flow from operations and its working capital position in subsequent periods.
Industry Context
StockSavvy.ai notes that ReposiTrak's focus on FSMA 204 compliance and traceability solutions aligns with significant regulatory drivers and increasing industry demand for supply chain visibility and safety. The extended compliance deadline for FSMA 204 to July 2028, while providing more time, is also spurring early adoption due to commercial and competitive pressures, as highlighted by retailers implementing stricter requirements.
Legal Proceedings
- There is currently no pending or threatened material legal proceeding that, in the opinion of management, could have a material adverse effect on the business or financial condition.
Related Party Transactions
- The company paid Riverview Financial Corp $834,773 for executive management services during the nine months ended March 31, 2026.
- The company redeemed Series B Preferred stock from Randall K. Fields, his affiliates, and Robert W. Allen totaling $1,752,330 during the nine months ended March 31, 2026.
Stakeholder Impact
- Shareholders: Continued payment of quarterly dividends and potential for future growth in net income and share value.
- Creditors: The company has no bank debt and maintains a strong current ratio, indicating good financial health.
- Suppliers/Distributors: The company's traceability solutions are critical for their compliance with FSMA 204 and other regulatory requirements.
- Employees: Continued investment in R&D and sales/marketing may lead to growth opportunities. Stock-based compensation is a component of employee compensation.
Next Steps
- Continue to focus sales efforts on recurring subscription revenue.
- Deemphasize non-recurring transactional revenue where possible.
- Continue development of software for FSMA 204 compliance and customer onboarding.
- Monitor and manage credit risk associated with the SPAR Marketing Force, Inc. note receivable.
- Redeem remaining Series B Preferred stock by December 2026.
- Continue to pay quarterly cash dividends to shareholders.
Key Dates
| Date | Description |
|---|---|
| 2023-12-21 | Company effected a change of its corporate name from Park City Group, Inc. to ReposiTrak, Inc. |
| 2024-03-15 | Company chose not to renew the Revolving Credit Agreement. |
| 2025-03-31 | Balance sheet date for the consolidated condensed balance sheets. |
| 2025-03-31 | End of the nine-month period for consolidated condensed statements of operations and comprehensive income. |
| 2025-03-31 | End of the nine-month period for consolidated condensed statements of cash flows. |
| 2025-03-31 | End of the nine-month period for consolidated condensed statements of stockholders equity. |
| 2025-05-14 | Filing date of the Form 10-Q. |
| 2026-03-17 | Date of Amended and Restated Senior Unsecured Promissory Note with SPAR Marketing Force, Inc. |
| 2026-03-20 | Date the Company's Board of Directors declared a quarterly cash dividend. |
| 2026-03-31 | End of the quarterly period for the consolidated condensed balance sheets. |
| 2026-03-31 | End of the three-month period for consolidated condensed statements of operations and comprehensive income. |
| 2026-03-31 | End of the three-month period for consolidated condensed statements of cash flows. |
| 2026-03-31 | End of the three-month period for consolidated condensed statements of stockholders equity. |
| 2026-05-14 | Filing date of the Form 10-Q. |
| 2026-05-15 | Expected payment date for the quarterly cash dividend declared on March 20, 2026. |
| 2026-07-20 | Extended compliance deadline for FSMA 204. |
| 2026-12-31 | Company intends to redeem all Series B and B-1 Preferred on or before this date. |
Recommendation
holdThe company demonstrates consistent profitability and strategic positioning in a growing regulatory-driven market. However, the slight revenue decline in the quarter, increased use of cash in financing activities, and the credit risk associated with the SPAR note warrant a cautious 'hold' recommendation until these factors are further clarified or resolved.
Keywords
ReposiTrak, SEC Filing, 10-Q, Quarterly Report, SaaS, Supply Chain Management, Food Safety, Traceability, FSMA 204, Financial Results, Revenue, Net Income
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.